Types of Intimate Partner Violence and Women's Health
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03469739|
Recruitment Status : Completed
First Posted : March 19, 2018
Last Update Posted : March 19, 2018
|Condition or disease|
Intimate partner violence (IPV) has detrimental effects on physical and mental health, risks to children and is associated with wider societal and healthcare costs. Previous analysis of the WHO multi-country study on women's health and domestic violence found significant associations between physical and sexual IPV and self-reported ill-health, symptomatology and suicidal behaviours.
Real experience of IPV can comprise different combinations of emotional, physical and sexual abuse, and different timings and frequencies of these. A more nuanced testing of exposure to these different combinations of IPV and associations with health is needed.
This study uses data from 29,990 women from 12 different countries collected by the WHO multi-country study on women's health and domestic violence to capture the effect of different combination types, frequency and timing of IPV on self-reported health, symptoms and suicidal behaviours.
|Study Type :||Observational|
|Actual Enrollment :||29990 participants|
|Official Title:||Types of Intimate Partner Violence and Women's Health: Findings From the WHO Multi-country Study on Women's Health and Intimate Partner Violence|
|Study Start Date :||June 2016|
|Actual Primary Completion Date :||August 2017|
|Actual Study Completion Date :||August 2017|
- Participant description of their current overall state of health [ Time Frame: Preceding 4 weeks ]Participant description of their current overall state of health- a choice of options- excellent, good, fair, poor or very poor.
- Participant reported health in the last 4 weeks- problems walking around, doing usual activities, pain or discomfort, problems with memory or concentration, dizziness or vaginal discharge. Measured by questionnaire. [ Time Frame: Preceding 4 weeks ]Participant rating of various health aspects in last 4 weeks
- Emotional distress. Measured by questionnaire of 20 different symptoms of emotional distress. SRQ-20 (score of 20 different symptoms of emotional distress with yes/no answers) [ Time Frame: Preceding 4 weeks ]Self Reporting Questionnaire-20 (SRQ-20)- aggregate score of 20 different symptoms of emotional distress with yes/no answers
- Participant reported ever suicidal thoughts or attempts; measured by questionnaire. [ Time Frame: Up to 49 years ]Participants reporting ever having suicidal thoughts or ever attempting suicide
- Participant reported medication used for sleep/ pain; measured by questionnaire. [ Time Frame: Preceding 4 weeks ]Participants reporting medication use
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03469739
|Study Director:||Gene Feder, MD FRCGP||University of Bristol|
|Principal Investigator:||Lucy C Potter, MB ChB||University of Bristol|